BEAM Q2 2020 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

BEAMBeam Therapeutics Inc.

$3B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6,000+0.0% YoY

Gross Profit

-$19M-322466.7% margin

Operating Income

-$26M-438083.3% margin

Net Income

-$34M-570300.0% margin

EPS (Diluted)

$-0.69

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$25M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$300M

Total Liabilities

$69M

Stockholders' Equity

$231M

Cash & Equivalents

$125M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6,000	$6,000	+0.0%
Gross Profit	-$19M	-$13M	-52.7%
Operating Income	-$26M	-$18M	-48.9%
Net Income	-$34M	-$18M	-91.6%